Artwork
iconShare
 
Manage episode 444326881 series 3578161
Content provided by Liam Eves and Ted Trafford, Liam Eves, and Ted Trafford. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Liam Eves and Ted Trafford, Liam Eves, and Ted Trafford or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford continue their discussion with Selin Kurnaz, CEO and founder of Massive Bio, an AI-powered platform that connects cancer patients with clinical trials. The conversation centers around the critical challenges in oncology trial enrollment, from recruitment failures to the operational difficulties encountered in the "Last Mile." We discuss the need for transparency, education, and a rethinking of traditional clinical trial processes. Selin discusses the complexity of site selection, prescreening, and patient identification, highlighting that the current system often overlooks the operational steps that are crucial for successful trial participation.

  continue reading

32 episodes